Relapse in schizophrenia



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Herz, M. I.
	Articles by Melville, C.
	Search for Related Content



	PubMed Citation
	Articles by Herz, M. I.
	Articles by Melville, C.

Am J Psychiatry 1980; 137:801-805
Copyright © 1980 by American Psychiatric Association

REGULAR ARTICLES

Relapse in schizophrenia

MI Herz and C Melville

Although schizophrenia is a chronic illness with exacerbations and remissions, there has been surprisingly little systematic study of early signs of relapse. The authors gave 145 chronic schizophrenic patients and 80 family members a structured interview regarding early signs of relapse and other information related to the relapse period. Most patients and family informants were aware of a prodromal period during which patients experienced such symptoms as having trouble sleeping, having trouble concentrating, loss of appetite, and feeling depressed. The authors discuss the implications of these findings for the treatment of chronic schizophrenic patients.

This article has been cited by other articles:

V. Crowley, J. Rose, J. Smith, K. Hobster, and E. Ansell
Psycho-educational groups for people with a dual diagnosis of psychosis and mild intellectual disability: A preliminary study
J Intellect Disabil., March 1, 2008; 12(1): 25 - 39.
[Abstract] [PDF]

M. B. Calzavara, W. A. Medrano, R. Levin, S. R. Kameda, M. L. Andersen, S. Tufik, R. H. Silva, R. Frussa-Filho, and V. C. Abilio
Neuroleptic Drugs Revert the Contextual Fear Conditioning Deficit Presented by Spontaneously Hypertensive Rats: A Potential Animal Model of Emotional Context Processing in Schizophrenia?
Schizophr Bull, February 16, 2008; (2008) sbn006v1.
[Abstract] [Full Text] [PDF]

M. J. Kikkert, A. H. Schene, M. W. J. Koeter, D. Robson, A. Born, H. Helm, M. Nose, C. Goss, G. Thornicroft, and R. J. Gray
Medication Adherence in Schizophrenia: Exploring Patients', Carers' and Professionals' Views
Schizophr Bull, October 1, 2006; 32(4): 786 - 794.
[Abstract] [Full Text] [PDF]

M. H. Chakos, I. D. Glick, A. L. Miller, M. B. Hamner, D. D. Miller, J. K. Patel, A. Tapp, R. S. E. Keefe, and R. A. Rosenheck
Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Psychiatr Serv, August 1, 2006; 57(8): 1094 - 1101.
[Abstract] [Full Text] [PDF]

H. A. Nasrallah, S. D. Targum, R. Tandon, J. S. McCombs, and R. Ross
Defining and Measuring Clinical Effectiveness in the Treatment of Schizophrenia
Psychiatr Serv, March 1, 2005; 56(3): 273 - 282.
[Abstract] [Full Text] [PDF]

N. R. Schooler
Maintenance Medication for Schizophrenia: Strategies for Dose Reduction
Focus, January 1, 2004; 2(1): 175 - 186.
[Abstract] [Full Text] [PDF]

L. Dixon, L. Green-Paden, J. Delahanty, A. Lucksted, L. Postrado, and J. Hall
Variables Associated With Disparities in Treatment of Patients With Schizophrenia and Comorbid Mood and Anxiety Disorders
Psychiatr Serv, September 1, 2001; 52(9): 1216 - 1222.
[Abstract] [Full Text] [PDF]

S. G. Siris
Depression in Schizophrenia: Perspective in the Era of "Atypical" Antipsychotic Agents
Am J Psychiatry, September 1, 2000; 157(9): 1379 - 1389.
[Abstract] [Full Text]

C. Mulholland and S. Cooper
The symptom of depression in schizophrenia and its management
Advan. Psychiatr. Treat., May 1, 2000; 6(3): 169 - 177.
[Full Text]

M. Birchwood, E. Spencer, and D. McGovern
Schizophrenia: early warning signs
Advan. Psychiatr. Treat., March 1, 2000; 6(2): 93 - 101.
[Full Text]

M. I. Herz, J. S. Lamberti, J. Mintz, R. Scott, S. P. O'Dell, L. McCartan, and G. Nix
A Program for Relapse Prevention in Schizophrenia: A Controlled Study
Arch Gen Psychiatry, March 1, 2000; 57(3): 277 - 283.
[Abstract] [Full Text] [PDF]

A. S. Young, O. Grusky, D. Jordan, and T. R. Belin
Routine Outcome Monitoring in a Public Mental Health System: The Impact of Patients Who Leave Care
Psychiatr Serv, January 1, 2000; 51(1): 85 - 91.
[Abstract] [Full Text] [PDF]

W. T. Carpenter Jr., R. W. Buchanan, B. Kirkpatrick, and A. F. Breier
Diazepam Treatment of Early Signs of Exacerbation in Schizophrenia
Am J Psychiatry, February 1, 1999; 156(2): 299 - 303.
[Abstract] [Full Text]

J. A. Cramer and R. Rosenheck
Compliance With Medication Regimens for Mental and Physical Disorders
Psychiatr Serv, February 1, 1998; 49(2): 196 - 201.
[Abstract] [Full Text]

K. H. Littrell and L. Y. Freeman
Maximizing Psychosocial Interventions
Journal of the American Psychiatric Nurses Association, December 1, 1995; 1(6): 214 - 218.
[Abstract] [PDF]

E. C. Johnstone, T.J. Crow, D.G.C. Owens, and C.D. Frith
The Northwick Park 'Functional' Psychosis Study. Phase 2: maintenance treatment
J Psychopharmacol, January 1, 1991; 5(4): 388 - 395.
[Abstract] [PDF]

M. R. Mandel, J. B. Severe, N. R. Schooler, A. J. Gelenberg, and M. Mieske
Development and Prediction of Postpsychotic Depression in Neuroleptic-Treated Schizophrenics
Arch Gen Psychiatry, February 1, 1982; 39(2): 197 - 203.
[Abstract] [PDF]

Get information about faster international access.